Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 May 27;310(6991):1375–1380. doi: 10.1136/bmj.310.6991.1375

Diagnosis and management of Clostridium difficile infection.

S Tabaqchali 1, P Jumaa 1
PMCID: PMC2549751  PMID: 7787544

Full text

PDF
1377

Images in this article

1377FIG 1
on p.1377
1377FIG 2
on p.1377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacon A. E., Fekety R., Schaberg D. R., Faix R. G. Epidemiology of Clostridium difficile colonization in newborns: results using a bacteriophage and bacteriocin typing system. J Infect Dis. 1988 Aug;158(2):349–354. doi: 10.1093/infdis/158.2.349. [DOI] [PubMed] [Google Scholar]
  2. Bartlett J. G., Chang T. W., Gurwith M., Gorbach S. L., Onderdonk A. B. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978 Mar 9;298(10):531–534. doi: 10.1056/NEJM197803092981003. [DOI] [PubMed] [Google Scholar]
  3. Bartlett J. G. Treatment of antibiotic-associated pseudomembranous colitis. Rev Infect Dis. 1984 Mar-Apr;6 (Suppl 1):S235–S241. doi: 10.1093/clinids/6.supplement_1.s235. [DOI] [PubMed] [Google Scholar]
  4. Brazier J. S. Role of the laboratory in investigations of Clostridium difficile diarrhea. Clin Infect Dis. 1993 Jun;16 (Suppl 4):S228–S233. doi: 10.1093/clinids/16.supplement_4.s228. [DOI] [PubMed] [Google Scholar]
  5. Cane P. A., Matthews D. A., Pringle C. R. Analysis of respiratory syncytial virus strain variation in successive epidemics in one city. J Clin Microbiol. 1994 Jan;32(1):1–4. doi: 10.1128/jcm.32.1.1-4.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cartmill T. D., Panigrahi H., Worsley M. A., McCann D. C., Nice C. N., Keith E. Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hosp Infect. 1994 May;27(1):1–15. doi: 10.1016/0195-6701(94)90063-9. [DOI] [PubMed] [Google Scholar]
  7. Fekety R., Kim K. H., Brown D., Batts D. H., Cudmore M., Silva J., Jr Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. Am J Med. 1981 Apr;70(4):906–908. doi: 10.1016/0002-9343(81)90553-2. [DOI] [PubMed] [Google Scholar]
  8. George R. H., Symonds J. M., Dimock F., Brown J. D., Arabi Y., Shinagawa N., Keighley M. R., Alexander-Williams J., Burdon D. W. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br Med J. 1978 Mar 18;1(6114):695–695. doi: 10.1136/bmj.1.6114.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. George W. L., Sutter V. L., Goldstein E. J., Ludwig S. L., Finegold S. M. Aetiology of antimicrobial-agent-associated colitis. Lancet. 1978 Apr 15;1(8068):802–803. doi: 10.1016/s0140-6736(78)93001-5. [DOI] [PubMed] [Google Scholar]
  10. Gumerlock P. H., Tang Y. J., Meyers F. J., Silva J., Jr Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces. Rev Infect Dis. 1991 Nov-Dec;13(6):1053–1060. doi: 10.1093/clinids/13.6.1053. [DOI] [PubMed] [Google Scholar]
  11. Hafiz S., Oakley C. L. Clostridium difficile: isolation and characteristics. J Med Microbiol. 1976 May;9(2):129–136. doi: 10.1099/00222615-9-2-129. [DOI] [PubMed] [Google Scholar]
  12. Heard S. R., O'Farrell S., Holland D., Crook S., Barnett M. J., Tabaqchali S. The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. J Infect Dis. 1986 Jan;153(1):159–162. doi: 10.1093/infdis/153.1.159. [DOI] [PubMed] [Google Scholar]
  13. Kabins S. A., Spira T. J. Outbreak of clindamycin-associated colitis. Ann Intern Med. 1975 Dec;83(6):830–831. doi: 10.7326/0003-4819-83-6-830. [DOI] [PubMed] [Google Scholar]
  14. Kelly C. P., Pothoulakis C., Orellana J., LaMont J. T. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding. Gastroenterology. 1992 Jan;102(1):35–40. doi: 10.1016/0016-5085(92)91781-x. [DOI] [PubMed] [Google Scholar]
  15. Khan M. Y., Hall W. H. Staphylococcal enterocolitis--treatment with oral vancomycin. Ann Intern Med. 1966 Jul;65(1):1–8. doi: 10.7326/0003-4819-65-1-1. [DOI] [PubMed] [Google Scholar]
  16. Larson H. E., Parry J. V., Price A. B., Davies D. R., Dolby J., Tyrrell D. A. Undescribed toxin in pseudomembranous colitis. Br Med J. 1977 May 14;1(6071):1246–1248. doi: 10.1136/bmj.1.6071.1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Larson H. E., Price A. B., Honour P., Borriello S. P. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet. 1978 May 20;1(8073):1063–1066. doi: 10.1016/s0140-6736(78)90912-1. [DOI] [PubMed] [Google Scholar]
  18. McFarland L. V., Mulligan M. E., Kwok R. Y., Stamm W. E. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989 Jan 26;320(4):204–210. doi: 10.1056/NEJM198901263200402. [DOI] [PubMed] [Google Scholar]
  19. Miller P. D., Pothoulakis C., Baeker T. R., LaMont J. T., Rothstein T. L. Macrophage-dependent stimulation of T cell-depleted spleen cells by Clostridium difficile toxin A and calcium ionophore. Cell Immunol. 1990 Mar;126(1):155–163. doi: 10.1016/0008-8749(90)90308-e. [DOI] [PubMed] [Google Scholar]
  20. Mulligan M. E., Peterson L. R., Kwok R. Y., Clabots C. R., Gerding D. N. Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol. 1988 Jan;26(1):41–46. doi: 10.1128/jcm.26.1.41-46.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pothoulakis C., Sullivan R., Melnick D. A., Triadafilopoulos G., Gadenne A. S., Meshulam T., LaMont J. T. Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest. 1988 Jun;81(6):1741–1745. doi: 10.1172/JCI113514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tabaqchali S., O'Farrell S., Nash J. Q., Wilks M. Vaginal carriage and neonatal acquisition of Clostridium difficile. J Med Microbiol. 1984 Aug;18(1):47–53. doi: 10.1099/00222615-18-1-47. [DOI] [PubMed] [Google Scholar]
  23. Tabaqchali S., Wilks M. Epidemiological aspects of infections caused by Bacteroides fragilis and Clostridium difficile. Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1049–1057. doi: 10.1007/BF01967798. [DOI] [PubMed] [Google Scholar]
  24. Teasley D. G., Gerding D. N., Olson M. M., Peterson L. R., Gebhard R. L., Schwartz M. J., Lee J. T., Jr Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet. 1983 Nov 5;2(8358):1043–1046. doi: 10.1016/s0140-6736(83)91036-x. [DOI] [PubMed] [Google Scholar]
  25. Tedesco F. J., Barton R. W., Alpers D. H. Clindamycin-associated colitis. A prospective study. Ann Intern Med. 1974 Oct;81(4):429–433. doi: 10.7326/0003-4819-81-4-429. [DOI] [PubMed] [Google Scholar]
  26. Walley T., Milson D. Loperamide related toxic megacolon in Clostridium difficile colitis. Postgrad Med J. 1990 Jul;66(777):582–582. doi: 10.1136/pgmj.66.777.582-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wilcox M. H., Spencer R. C. Clostridium difficile infection: responses, relapses and re-infections. J Hosp Infect. 1992 Oct;22(2):85–92. doi: 10.1016/0195-6701(92)90092-z. [DOI] [PubMed] [Google Scholar]
  28. Wren B. W., Heard S. R., al-Saleh A. I., Tabaqchali S. Characterisation of Clostridium difficile strains by polymerase chain reaction with toxin A- and B-specific primers. J Med Microbiol. 1993 Feb;38(2):109–113. doi: 10.1099/00222615-38-2-109. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES